Birgitta Rembeck

Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population

M. Z�ller, Birgitta Rembeck, Anders Od�n et al. · Cancer · 1997 · 382 citations · Full text

Medicine, Oncology, Pathology +13

Life expectancy, mortality and prognostic factors in neurofibromatosis type 1. A twelve-year follow-up of an epidemiological study in Göteborg, Sweden.

Madeleine E.T. Zöller, Birgitta Rembeck, Hans Olof Åkesson et al. · Acta Dermato Venereologica · 1995 · 175 citations · Full text

Medicine, Neurology, Oncology +12

Neuropsychological deficits in adults with Neurofibromatosis type 1

Madeleine E.T. Zöller, Birgitta Rembeck, Lars Bäckman · Acta Neurologica Scandinavica · 1997 · 51 citations

Medicine, Neurology, Psychiatry +17

Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population

Madeleine E.T. Zöller, Birgitta Rembeck, Anders Odén et al. · Cancer · 1997 · 35 citations

Medicine, Oncology, Pathology +13

L-lysine as adjunctive treatment in patients with schizophrenia: a single-blinded, randomized, cross-over pilot study

Caroline Wass, Daniel Klamer, Evangelos Katsarogiannis et al. · BMC Medicine · 2011 · 27 citations · Full text

Medicine, Pharmacology, Psychiatry +17